Result of AGM
hVIVO plc announced that all resolutions presented at its Annual General Meeting held on May 13, 2026, were duly passed by shareholders. The company, a leader in human challenge trials and a full-service clinical development partner, will publish the detailed voting results on its website shortly. This confirmation of shareholder support for all proposed resolutions suggests continued confidence in the company's governance and strategic direction.
Select text to share a quote on X · sign in to keep highlights & notes in your HVO notes
London, UK - 13 May 2026, hVIVO plc (AIM: HVO), a purpose-built, full-service international clinical development partner and the world leader in human challenge trials, announces that all resolutions put to shareholders at the Company's Annual General Meeting ('AGM') held earlier today were duly passed.
The voting results of the AGM will be published on the Company website shortly: https://hvivo.com/company-documents/
| Peel Hunt LLP (Joint Broker) | +44 (0)20 7418 8900 |
| James Steel, Dr Christopher Golden | |
| Davy (Joint Broker) | +353 (0) 1 679 6363 |
Anthony Farrell, Niall Gilchrist
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.